Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06424756 · ClinicalTrials.gov registry record · Phase 2

Effects of an Antioxidant Supplement on Blood Vessel Health

A Phase 2 study of Healthy, sponsored by University of Georgia.

Recruiting
Registry status
Phase 2
Development phase
60
Enrollment target
1
Study location

NCT06424756 is a Phase 2 study of Healthy that is actively recruiting participants, run by University of Georgia. The registered enrollment target is 60 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06424756, a Phase 2 study of Healthy, is actively recruiting participants, sponsored by University of Georgia.

RECRUITING
Registry status
Phase 2
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, and the non-Hispanic Black (NHB) population is disproportionately affected. Our research has previously demonstrated that oxidative stress may contribute to reduced vascular function in otherwise healthy NHB adults, potentially predisposing them to the development of hypertension and CVD. This study is designed to examine whether the mitochondria are an important source of oxidative stress-induced vascular dysfunction in healthy NHB adults.

Conditions Studied

Healthy

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT MitoQ
  • DRUG Tempol
  • DRUG L-NAME
  • DRUG MitoTempo

Study Locations (1)

Georgia

  • Ramsey Student Center, University of Georgia - Athens

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-07-01
Est. Completion 2030-03-31
Phase Phase 2

Sponsor

University of Georgia

59 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06424756

The ClinicalTrials.gov registry entry for NCT06424756 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.

NCT06424756 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06424756 about?

NCT06424756 is a clinical study titled "Effects of an Antioxidant Supplement on Blood Vessel Health". Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, and the non-Hispanic Black (NHB) population is disproportionately affected. Our research has previously demonstrated that oxidative stress may contribute to reduced vascular function in otherwise healthy NHB adults...

What is the current status of trial NCT06424756?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2024-07-01. Estimated completion is 2030-03-31.

What conditions does trial NCT06424756 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06424756?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), MitoQ (DIETARY_SUPPLEMENT), Tempol (DRUG), L-NAME (DRUG), MitoTempo (DRUG).

Who is sponsoring clinical trial NCT06424756?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06424756 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.